Faculty profile

Wassim Kassouf

ResearcherSurgeryMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.

Wassim Kassouf

Researcher

Surgery

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
64 publications in the last five years, latest in 2026.
Senior (last) author on 14 recent papers, a sign of leading a research group.
Principal investigator on 4 research grants (4 CIHR), most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

257

Publications

860

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Bladder Cancer Microbiome Radiation Immunology Immunotherapy Metabolome Nuclear Extracellular Trap Radiation Therapy

Latest papers

Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group.
Nature reviews. Urology · 2026
A minor high-grade component in non-invasive papillary urothelial carcinoma is not associated with a more indolent behaviour.
Histopathology · 2026
Oncological Outcomes of Nonmuscle-Invasive Bladder Cancer in Patients Aged 45 Years and Younger: A Retrospective Matched Cohort Study.
The Journal of urology · 2026

All 257 publications

Latest funding

Unraveling immune-microbiome networks in radiation-based organ-preserving therapies for muscle-invasive bladder cancer
CIHR · 2024 · Nominated PI
$1,507,050
Metabolism/Metagenomics-based strategies for sensitization to Radio- and Immuno-therapy Combinations.
CIHR · 2024 · Nominated PI
$300,000
A SMART design to optimize the delivery of TEMPO - a Tailored, wEb-based psychosocial and physical activity self-Management PrOgram for men with prostate cancer and their caregivers
CIHR · 2023 · Co-investigator
$761,176

All 10 grants and awards

From the 150 most recent of 257 publications.

Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group.

Hensley PJ, Teoh JYC, Li R, Gupta S, Bukavina L, Mouw KW, Lobo N, Maiorano BA, Tan WS, Agarwal P, Al-Ahmadie HA, Bivalacqua TJ, Cheng L, Flaig TW, Guo CC, Horowitz A, Kassouf W, Kates MR, Konety BR, Kukreja JB, Lotan Y, McConkey DJ, Mertens LS, Mir MC, Moschini M, Necchi A, Oualla K, Packiam VT, Schmidt B, Buckley RJ, Kamat AM

Nature reviews. Urology2026

DOI: 10.1038/s41585-026-01179-y PMID: 42557383

A minor high-grade component in non-invasive papillary urothelial carcinoma is not associated with a more indolent behaviour.

Farag MS, Oghbaei N, Hussain J, Lametti A, Kassouf W, Brimo F

Histopathology2026

DOI: 10.1111/his.70086 PMID: 41456876

Oncological Outcomes of Nonmuscle-Invasive Bladder Cancer in Patients Aged 45 Years and Younger: A Retrospective Matched Cohort Study.

St-Laurent MP, Din S, Moryousef J, Lajkosz K, Kwong JCC, Chan A, Kim J, Taborek A, Chadee A, Sadri I, Reznik G, Tin C, Fleshner NE, Kulkarni GS, Black PC, Kassouf W, Zlotta AR

The Journal of urology2026

DOI: 10.1097/ju.0000000000005183 PMID: 42341207

Development and International Evaluation of an Artificial Intelligence-based Model (PROGRxN-BCa) Using the World Health Organization 2004/2022 Grading System to Predict Progression Risk and Improve Substratification for Non-muscle-invasive Bladder Cancer.

Kwong JCC, Al-Daqqaq Z, Chelliahpillai Y, Lee S, Kim K, Ringa M, Feifer A, Lajkosz K, Wettstein MS, Chan A, Lee T, Nguyen M, Kassouf W, Black PC, Breau RH, Lodde M, Fairey A, Lattouf JB, Jeldres C, Rendon R, Alimohamed N, Fleshner NE, Diamand R, Gontero P, Sylvester RJ, van Rhijn BWG, Kamat AM, Johnson AEW, Zlotta AR, Kulkarni GS, PROGRxN-BCa Consortium

European urology2026

DOI: 10.1016/j.eururo.2025.09.4145 PMID: 41062388

The Clinical Relevance of Tertiary Lymphoid Structures in Assessing Treatment Response in Muscle-Invasive Bladder Cancer.

Hassan N, Michaud E, Mansure JJ, Farag M, Kool R, Alessa M, Sadri E, Cury F, Brimo F, Koti M, Kassouf W

International journal of radiation oncology, biology, physics2026Senior author

DOI: 10.1016/j.ijrobp.2025.09.056 PMID: 41135713

Integrating novel immunotherapeutic approaches in organ-preserving therapies for bladder cancer.

Michaud É, Mansure JJ, Kassouf W

British journal of pharmacology2026Senior author

DOI: 10.1111/bph.16300 PMID: 38092703

Role of Second-Look Ureterorenoscopy After Endoscopic Treatment of Upper Tract Urothelial Carcinoma.

Abufaraj M, Foerster B, Muilwijk T, Marcq G, Seisen T, Li R, Monteiro LL, Bandini M, Schweitzer D, Kenigsberg A, D'Andrea D, Hendricksen K, Soria F, Fallara G, Joniau S, Xylinas E, Moschini M, Rouprêt M, Briganti A, Spiess PE, Kassouf W, Guruli G, John H, Enikeev D, Azizi M, Colin P, Shariat SF

Cancers2026

DOI: 10.3390/cancers18172893 PMID: 42738413

Cost-effectiveness Analysis of Treatments for Bacillus Calmette-Guérin-unresponsive Carcinoma in Situ of the Bladder.

Myers AA, Talwar R, Duan Z, Hensley P, Lotan Y, Williams SB, Luckenbaugh AN, Li R, Kassouf W, Necchi A, Packiam VT, Shore N, Steinberg GD, Witjes JA, Schmidt B, Porten S, Hahn NM, Bree KK, Toumazis I, Zhao H, Kamat AM

European urology2026

DOI: 10.1016/j.eururo.2025.09.4137 PMID: 41046180

Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer Group.

Gupta S, Hensley PJ, Li R, Choudhury A, Daneshmand S, Faltas BM, Flaig TW, Grass GD, Grivas P, Hansel DE, Hassanzadeh C, Kassouf W, Kukreja J, Mendoza-Valdés A, Moschini M, Mouw KW, Navai N, Necchi A, Rosenberg JE, Ross JS, Siefker-Radtke AO, Taylor J, Willliams SB, Zlotta AR, Buckley R, Kamat AM

European urology2026

DOI: 10.1016/j.eururo.2025.03.017 PMID: 40268594

Clinical significance of stratifying prostate cancer patients through specific circulating genes.

Derderian S, Jarry E, Santos A, Vesval Q, Hamel L, Sanchez-Salas R, Rompré-Brodeur A, Kassouf W, Rajan R, Brimo F, Duclos M, Aprikian A, Chevalier S

Molecular oncology2025

DOI: 10.1002/1878-0261.13805 PMID: 39840448

Something wrong or missing on this profile? Suggest a correction

Wassim Kassouf

Research

Latest papers

Latest funding

Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group.

A minor high-grade component in non-invasive papillary urothelial carcinoma is not associated with a more indolent behaviour.

Oncological Outcomes of Nonmuscle-Invasive Bladder Cancer in Patients Aged 45 Years and Younger: A Retrospective Matched Cohort Study.

Development and International Evaluation of an Artificial Intelligence-based Model (PROGRxN-BCa) Using the World Health Organization 2004/2022 Grading System to Predict Progression Risk and Improve Substratification for Non-muscle-invasive Bladder Cancer.

The Clinical Relevance of Tertiary Lymphoid Structures in Assessing Treatment Response in Muscle-Invasive Bladder Cancer.

Integrating novel immunotherapeutic approaches in organ-preserving therapies for bladder cancer.

Role of Second-Look Ureterorenoscopy After Endoscopic Treatment of Upper Tract Urothelial Carcinoma.

Cost-effectiveness Analysis of Treatments for Bacillus Calmette-Gu&#xe9;rin-unresponsive Carcinoma in Situ of the Bladder.

Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer Group.

Clinical significance of stratifying prostate cancer patients through specific circulating genes.

Frequent collaborators

Bobby Shayegan

Alice Dragomir

Alan So

Peter Black

Ilias Cagiannos

Philippe Violette

Robert Siemens

Girish Kulkarni

Libni Eapen

Antonio Finelli

Neil Fleshner

Madhuri Koti

Aly-Khan Lalani

Vincent Fradet

Victor McPherson

Christina Canil

Jan Seuntjens

Paul Toren

Stephen Pautler

Nicholas Power

Marie-Pier St-Laurent

David Berman

Michael Ong

Eric Winquist

Jehonathan Pinthus

Som Mukherjee

Sebastien Hotte

Edward Matsumoto

Krista Noonan

Miles Mannas

Tracy Stockley

Alp Sener

ANDREW FEIFER

Salmaan Kanji

Jean-Mathieu Beauregard

Bernhard Eigl

Dawn Stacey

Ronald Moore

Yasser Riazalhosseini

Robert Hamilton

Cost-effectiveness Analysis of Treatments for Bacillus Calmette-Guérin-unresponsive Carcinoma in Situ of the Bladder.